申请人:——
公开号:US20020103183A1
公开(公告)日:2002-08-01
Compounds of Formula I, and pharmaceutical compositions containing these compounds, activate the insulin receptor kinase, which leads to an increased sensitivity to insulin and an increase in glucose uptake, and are therefore useful for the treatment of animals, especially humans, with hyperglycemia, especially for the treatment of type 2 diabetes. Processes for preparation of the compounds, and their use in assays, are also disclosed.
公式I的化合物及含有这些化合物的制药组合物,可以激活胰岛素受体激酶,从而提高对胰岛素的敏感性和葡萄糖摄取量,因此可用于治疗动物,尤其是人类的高血糖,特别是用于治疗2型糖尿病。还公开了制备这些化合物的过程以及它们在测定中的应用。